HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis - involvement of ERK pathway

FEBS Letters

Volumn 580, Issue 11, 2006, Pages 2779-2787

  Wang, Jing ^a   Shen, Ying H ^a   Utama, Budi ^a   Wang, Jian ^a   LeMaire, Scott A ^a   Coselli, Joseph S ^a   Vercellotti, Greg M ^b   Wang, Xing Li ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Apoptosis; Cytomegalovirus; Endothelium; Hydrogen peroxide

Indexed keywords

HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2;

AORTA; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MOLECULAR MECHANICS; PRIORITY JOURNAL; UPREGULATION; VIRUS STRAIN;

APOPTOSIS; CASPASE 3; CASPASES; CELLS, CULTURED; CYTOMEGALOVIRUS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; HYDROGEN PEROXIDE; INTRACELLULAR MEMBRANES; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIALS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; UP-REGULATION;

HUMAN HERPESVIRUS 5;

EID: 33646477958     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.04.041     Document Type: Article

References (45)

1. Nerheim P.L., et al. Enhanced cytomegalovirus infection in atherosclerotic human blood vessels. Am. J. Pathol. 164 (2004) 589-600
2. Tanaka K., Zou J.P., Takeda K., Ferrans V.J., Sandford G.R., Johnson T.M., Finkel T., and Epstein S.E. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation 99 (1999) 1656-1659
3. Zhou Y.F., Leon M.B., Waclawiw M.A., Popma J.J., Yu Z.X., Finkel T., and Epstein S.E. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 335 (1996) 624-630
4. Trincado D.E., and Rawlinson W.D. Congenital and perinatal infections with cytomegalovirus. J. Paediatr. Child Health 37 (2001) 187-192
5. Wang J., Marker P.H., Belcher J.D., Wilcken D.E., Burns L.J., Vercellotti G.M., and Wang X.L. Human cytomegalovirus immediate early proteins upregulate endothelial p53 function. FEBS Lett. 474 (2000) 213-216
6. Kovacs A., Weber M.L., Burns L.J., Jacob H.S., and Vercellotti G.M. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am. J. Pathol. 149 (1996) 1531-1539
7. Shen Y.H., et al. Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways. Circ. Res. 94 (2004) 1310-1317
8. Skaletskaya A., Bartle L.M., Chittenden T., McCormick A.L., Mocarski E.S., and Goldmacher V.S. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA 98 (2001) 7829-7834
9. Goldmacher V.S. vMIA, a viral inhibitor of apoptosis targeting mitochondria. Biochimie 84 (2002) 177-185
10. Zhu H., Shen Y., and Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69 (1995) 7960-7970
11. Waldman W.J., Sneddon J.M., Stephens R.E., and Roberts W.H. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J. Med. Virol. 28 (1989) 223-230
12. Goldmacher V.S. Cell death suppression by cytomegaloviruses. Apoptosis 10 (2005) 251-265
13. Castillo J.P., and Kowalik T.F. HCMV infection: modulating the cell cycle and cell death. Int. Rev. Immunol. 23 (2004) 113-139
14. Polster B.M., Pevsner J., and Hardwick J.M. Viral Bcl-2 homologs and their role in virus replication and associated diseases. Biochim. Biophys. Acta 1644 (2004) 211-227
15. Benedict C.A., Norris P.S., and Ware C.F. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3 (2002) 1013-1018
16. Favata M.F., et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273 (1998) 18623-18632
17. Yonemitsu Y. Viruses and vascular disease. Nat. Med. 4 (1998) 253-254
18. Grattan M.T., Moreno-Cabral C.E., Starnes V.A., Oyer P.E., Stinson E.B., and Shumway N.E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261 (1989) 3561-3566
19. Colavitti R., Pani G., Bedogni B., Anzevino R., Borrello S., Waltenberger J., and Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J. Biol. Chem. 277 (2002) 3101-3108
20. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc. Res. 68 (2005) 26-36
21. Chen K., Thomas S.R., Albano A., Murphy M.P., and Keaney Jr. J.F. Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling. J. Biol. Chem. 279 (2004) 35079-35086
22. Lin S.J., Shyue S.K., Liu P.L., Chen Y.H., Ku H.H., Chen J.W., Tam K.B., and Chen Y.L. Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways. J. Mol. Cell Cardiol. 36 (2004) 129-139
23. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25 (2003) 17-24
24. Nicot C., Astier-Gin T., and Guillemain B. Activation of Bcl-2 expression in human endothelial cells chronically expressing the human T-cell lymphotropic virus type I. Virology 236 (1997) 47-53
25. Ackermann E.J., Taylor J.K., Narayana R., and Bennett C.F. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J. Biol. Chem. 274 (1999) 11245-11252
26. Meilhac O., Escargueil-Blanc I., Thiers J.C., Salvayre R., and Negre-Salvayre A. Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB J. 13 (1999) 485-494
27. Badrichani A.Z., Stroka D.M., Bilbao G., Curiel D.T., Bach F.H., and Ferran C. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J. Clin. Invest. 103 (1999) 543-553
28. Cai J., Ahmad S., Jiang W.G., Huang J., Kontos C.D., Boulton M., and Ahmed A. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes 52 (2003) 2959-2968
29. Arnoult D., et al. Cytomegalovirus cell death suppressor vMIA blocks Bax - but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc. Natl. Acad. Sci. USA 101 (2004) 7988-7993
30. Smith G.B., and Mocarski E.S. Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. J. Virol. 79 (2005) 14923-14932
31. Goldmacher V.S., et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA 96 (1999) 12536-12541
32. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87 (2000) 179-183
33. Tanaka T., Nakamura H., Yodoi J., and Bloom E.T. Redox regulation of the signaling pathways leading to eNOS phosphorylation. Free Radic. Biol. Med. 38 (2005) 1231-1242
34. Xie W., and Herschman H.R. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J. Biol. Chem. 270 (1995) 27622-27628
35. Pages G., Lenormand P., L'Allemain G., Chambard J.C., Meloche S., and Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90 (1993) 8319-8323
36. Milanini J., Vinals F., Pouyssegur J., and Pages G. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J. Biol. Chem. 273 (1998) 18165-18172
37. Liu Y.Z., Boxer L.M., and Latchman D.S. Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. Nucleic Acids Res. 27 (1999) 2086-2090
38. Anderson P. Kinase cascades regulating entry into apoptosis. Microbiol Mol. Biol. Rev. 61 (1997) 33-46
39. Kim R. Unknotting the roles of Bcl-2 and Bcl-xL in cell death. Biochem. Biophys. Res. Commun. 333 (2005) 336-343
40. Ruvolo P.P., Deng X., and May W.S. Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 15 (2001) 515-522
41. Furukawa Y., Iwase S., Kikuchi J., Terui Y., Nakamura M., Yamada H., Kano Y., and Matsuda M. Phosphorylation of Bcl-2 protein by CDC2 kinase during G2/M phases and its role in cell cycle regulation. J. Biol. Chem. 275 (2000) 21661-21667
42. Haldar S., Jena N., and Croce C.M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA 92 (1995) 4507-4511
43. Haldar S., Chintapalli J., and Croce C.M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56 (1996) 1253-1255
44. Ruvolo P.P., Deng X., Ito T., Carr B.K., and May W.S. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. 274 (1999) 20296-20300
45. Ito T., Deng X., Carr B., and May W.S. Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272 (1997) 11671-11673